Recent Advances in Nanotherapeutics for Neurological Disorders
暂无分享,去创建一个
M. Nair | Pandiaraj Manickam | Arti Vashist | A. Vashist | A. Y. Arias | N. Kolishetti | Andrea D Raymond | A. Raymond | Emanuel Arias | Nagesh Kolishetti
[1] M. Nair,et al. Multi-functional auto-fluorescent nanogels for theranostics , 2023, Journal of NeuroVirology.
[2] N. Thorat,et al. Exosome-Based Smart Drug Delivery Tool for Cancer Theranostics , 2023, ACS biomaterials science & engineering.
[3] N. Voelcker,et al. A Multifunctional Porous Silicon Nanocarrier for Glioblastoma Treatment. , 2022, Molecular pharmaceutics.
[4] Ki‐Bum Lee,et al. Advanced theragnostics for the central nervous system (CNS) and neurological disorders using functional inorganic nanomaterials. , 2022, Advanced drug delivery reviews.
[5] Xinmei Wang,et al. Exosomes—Nature’s Lipid Nanoparticles, a Rising Star in Drug Delivery and Diagnostics , 2022, ACS nano.
[6] Michał M Kłosowski,et al. Nanostars Carrying Multifunctional Neurotrophic Dendrimers Protect Neurons in Preclinical In Vitro Models of Neurodegenerative Disorders , 2022, ACS applied materials & interfaces.
[7] S. Kannan,et al. Dendrimer-siRNA Conjugates for Targeted Intracellular Delivery in Glioblastoma Animal Models. , 2022, ACS applied materials & interfaces.
[8] F. Ferrari,et al. Development of alginate-spermidine micro/nanogels as potential antioxidant and anti-inflammatory tool in peripheral nerve injuries. Formulation studies and physico-chemical characterization. , 2022, International journal of pharmaceutics.
[9] M. Suar,et al. Emerging trends in the nanomedicine applications of functionalized magnetic nanoparticles as novel therapies for acute and chronic diseases , 2022, Journal of Nanobiotechnology.
[10] Haiyan Liu,et al. Nanogels as Novel Nanocarrier Systems for Efficient Delivery of CNS Therapeutics , 2022, Frontiers in bioengineering and biotechnology.
[11] Yaolin Xu,et al. Brain Tumor Imaging and Delivery of Sub-5 nm Magnetic Iron Oxide Nanoparticles in an Orthotopic Murine Model of Glioblastoma , 2022, ACS Applied Nano Materials.
[12] S. Murugesan,et al. Liposomes: An emerging carrier for targeting Alzheimer's and Parkinson's diseases , 2022, Heliyon.
[13] Yuan-Lu Cui,et al. Hydrogen bond-enhanced nanogel delivery system for potential intranasal therapy of Parkinson's Disease , 2022, Materials & Design.
[14] M. Nair,et al. Recent advances, status, and opportunities of magneto-electric nanocarriers for biomedical applications. , 2021, Molecular aspects of medicine.
[15] Ying Zheng,et al. Engineered exosomes: desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies , 2021, Theranostics.
[16] Y. Loh,et al. Function of exosomes in neurological disorders and brain tumors , 2021, Extracellular Vesicles and Circulating Nucleic Acids.
[17] Hui Xie,et al. Dual-responsive biohybrid neutrobots for active target delivery , 2021, Science Robotics.
[18] N. Voelcker,et al. Development of Polymeric Nanoparticles for Blood–Brain Barrier Transfer—Strategies and Challenges , 2021, Advanced science.
[19] S. Sacanna,et al. Modulation of Immune Responses by Particle Size and Shape , 2021, Frontiers in Immunology.
[20] Lixiang Wang,et al. Development of L-carnosine functionalized iron oxide nanoparticles loaded with dexamethasone for simultaneous therapeutic potential of blood brain barrier crossing and ischemic stroke treatment , 2021, Drug delivery.
[21] Anjali Sharma,et al. Targeting Mitochondria in Tumor-Associated Macrophages using a Dendrimer Conjugated TSPO Ligand Stimulates Anti-Tumor Signaling in Glioblastoma. , 2020, Biomacromolecules.
[22] Jonghan Kim,et al. Intranasal Delivery and Transfection of mRNA Therapeutics in the Brain Using Cationic Liposomes. , 2020, Molecular pharmaceutics.
[23] M. Nair,et al. Development of Multifunctional Biopolymeric Auto-Fluorescent Micro- and Nanogels as a Platform for Biomedical Applications , 2020, Frontiers in Bioengineering and Biotechnology.
[24] S. Kannan,et al. Dendrimer size effects on the selective brain tumor targeting in orthotopic tumor models upon systemic administration , 2020, Bioengineering & translational medicine.
[25] Sanjay Arora,et al. Efficient neuronal targeting and transfection using RVG and transferrin-conjugated liposomes , 2020, Brain Research.
[26] Raghu Kalluri,et al. The biology, function, and biomedical applications of exosomes , 2020, Science.
[27] J. Ljubimova,et al. Magnetic iron oxide nanoparticles for imaging, targeting and treatment of primary and metastatic tumors of the brain. , 2020, Journal of controlled release : official journal of the Controlled Release Society.
[28] Anjali Sharma,et al. Dense hydroxyl polyethylene glycol dendrimer targets activated glia in multiple CNS disorders , 2020, Science Advances.
[29] D. G. Parambi,et al. Advancements in nanotherapeutics for Alzheimer’s disease: current perspectives , 2019, The Journal of pharmacy and pharmacology.
[30] Hongzhuan Chen,et al. Harnessing Exosomes for the Development of Brain Drug Delivery Systems. , 2019, Bioconjugate chemistry.
[31] S. M. Dizaj,et al. Applications of nanotechnology in drug delivery to the central nervous system. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[32] A. Anel,et al. Role of Exosomes in the Regulation of T-Cell Mediated Immune Responses and in Autoimmune Disease , 2018, Cells.
[33] Ling Zhang,et al. Dopamine‐loaded blood exosomes targeted to brain for better treatment of Parkinson's disease , 2018, Journal of controlled release : official journal of the Controlled Release Society.
[34] Xiaoyuan Chen,et al. Aptamer‐based targeted therapy , 2018, Advanced drug delivery reviews.
[35] M. Sawan,et al. Colloidal stability of superparamagnetic iron oxide nanoparticles in the central nervous system: a review. , 2018, Nanomedicine.
[36] C. Dispenza,et al. Nose‐to‐brain delivery of insulin enhanced by a nanogel carrier , 2018, Journal of controlled release : official journal of the Controlled Release Society.
[37] M. Chopp,et al. Exosomes Derived from Mesenchymal Stromal Cells Promote Axonal Growth of Cortical Neurons , 2016, Molecular Neurobiology.
[38] S. Kannan,et al. Nanoscale effects in dendrimer-mediated targeting of neuroinflammation. , 2016, Biomaterials.
[39] K. Ulbrich,et al. Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies. , 2016, Chemical reviews.
[40] C. Dispenza,et al. Ionizing radiation-engineered nanogels as insulin nanocarriers for the development of a new strategy for the treatment of Alzheimer's disease. , 2016, Biomaterials.
[41] O. Abdallah,et al. Intranasal Piperine-Loaded Chitosan Nanoparticles as Brain-Targeted Therapy in Alzheimer's Disease: Optimization, Biological Efficacy, and Potential Toxicity. , 2015, Journal of pharmaceutical sciences.
[42] F. Borràs,et al. Therapeutic Potential of Extracellular Vesicles , 2014, Front. Immunol..
[43] Abeer M. Al-Ghananeem,et al. Intranasal Drug Delivery of Olanzapine-Loaded Chitosan Nanoparticles , 2014, AAPS PharmSciTech.
[44] R. Vassar,et al. Neuron loss in the 5XFAD mouse model of Alzheimer’s disease correlates with intraneuronal Aβ42 accumulation and Caspase-3 activation , 2013, Molecular Neurodegeneration.
[45] York Winter,et al. Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease–like pathology and cognitive decline , 2012, Nature Medicine.
[46] D. Dickson,et al. Massive gliosis induced by interleukin‐6 suppresses Aβ deposition in vivo: evidence against inflammation as a driving force for amyloid deposition , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[47] G. Brewer,et al. Age‐ and concentration‐dependent neuroprotection and toxicity by TNF in cortical neurons from β‐amyloid , 2001, Journal of neuroscience research.
[48] W. Griffin,et al. Microglial inter leukin‐1α expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution , 1995, Neuropathology and applied neurobiology.